{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:37:40Z","timestamp":1782257860985,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ejphar.2020.173194","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T21:14:34Z","timestamp":1590009274000},"page":"173194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["ASP8477, a fatty acid amide hydrolase inhibitor, exerts analgesic effects in rat models of neuropathic and dysfunctional pain"],"prefix":"10.1016","volume":"881","author":[{"given":"Tetsuo","family":"Kiso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonari","family":"Watabiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Sekizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.173194_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2020.173194_bib2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1744-8069-7-52","article-title":"Streptozotocin-induced early thermal hyperalgesia is independent of glycemic state of rats: role of transient receptor potential vanilloid 1(TRPV1) and inflammatory mediators","volume":"7","author":"Bishnoi","year":"2011","journal-title":"Mol. Pain"},{"key":"10.1016\/j.ejphar.2020.173194_bib3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0014-2999(00)00211-9","article-title":"Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor","volume":"396","author":"Buckley","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173194_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ejphar.2020.173194_bib5","doi-asserted-by":"crossref","first-page":"10821","DOI":"10.1073\/pnas.0401292101","article-title":"Functional disassociation of the central and peripheral fatty acid amide signaling systems","volume":"101","author":"Cravatt","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2020.173194_bib6","doi-asserted-by":"crossref","first-page":"328797","DOI":"10.1155\/2013\/328797","article-title":"Palmitoylethanolamide is a disease-modifying agent in peripheral neuropathy: pain relief and neuroprotection share a PPAR-alpha-mediated mechanism","volume":"2013","author":"Di Cesare Mannelli","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ejphar.2020.173194_bib7","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0304-3959(98)00239-5","article-title":"Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat","volume":"80","author":"Field","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2020.173194_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40122-017-0091-4","article-title":"Pharmacotherapy for neuropathic pain: a review","volume":"6","author":"Fornasari","year":"2017","journal-title":"Pain Ther"},{"key":"10.1016\/j.ejphar.2020.173194_bib9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/7268","article-title":"Dopamine activation of endogenous cannabinoid signaling in dorsal striatum","volume":"2","author":"Giuffrida","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2020.173194_bib10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00001756-200203250-00020","article-title":"Capsaicin-sensitive primary afferents mediate responses to cold in rats with a peripheral mononeuropathy","volume":"13","author":"Hama","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.ejphar.2020.173194_bib11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(80)90515-4","article-title":"Intrathecal morphine in mice: a new technique","volume":"67","author":"Hylden","year":"1980","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173194_bib12","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/sj.bjp.0707433","article-title":"Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain","volume":"152","author":"Jhaveri","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173194_bib13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nm803","article-title":"Modulation of anxiety through blockade of anandamide hydrolysis","volume":"9","author":"Kathuria","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2020.173194_bib14","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0304-3959(92)90041-9","article-title":"An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat","volume":"50","author":"Kim","year":"1992","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2020.173194_bib15","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1111\/bph.14448","article-title":"Analgesic effects of ASP3662, a novel 11beta-hydroxysteroid dehydrogenase 1 inhibitor, in rat models of neuropathic and dysfunctional pain","volume":"175","author":"Kiso","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173194_bib16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12868-016-0273-8","article-title":"The preventive effect of resiniferatoxin on the development of cold hypersensitivity induced by spinal nerve ligation: involvement of TRPM8","volume":"17","author":"Koh","year":"2016","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.ejphar.2020.173194_bib17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1124\/jpet.104.069401","article-title":"Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity","volume":"311","author":"Lichtman","year":"2004","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173194_bib18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev.biochem.74.082803.133450","article-title":"Structure and function of fatty acid amide hydrolase","volume":"74","author":"McKinney","year":"2005","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejphar.2020.173194_bib19","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0006-8993(01)02069-8","article-title":"Characterization of the glutamatergic system for induction and maintenance of allodynia","volume":"895","author":"Minami","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2020.173194_bib20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pain.2006.06.016","article-title":"Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain","volume":"126","author":"Mitrirattanakul","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2020.173194_bib21","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1124\/jpet.113.208686","article-title":"AS1069562, the (+)-isomer of indeloxazine, exerts analgesic effects in a rat model of neuropathic pain with unique characteristics in spinal monoamine turnover","volume":"348","author":"Murai","year":"2014","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173194_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neuropharm.2017.08.032","article-title":"Analgesic effects of novel lysophosphatidic acid receptor 5 antagonist AS2717638 in rodents","volume":"126","author":"Murai","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2020.173194_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pbb.2015.11.008","article-title":"Spontaneous and evoked pain-associated behaviors in a rat model of neuropathic pain respond differently to drugs with different mechanisms of action","volume":"141","author":"Murai","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2020.173194_bib24","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1046\/j.1471-4159.2003.01840.x","article-title":"Functional characterization of prostaglandin F2alpha receptor in the spinal cord for tactile pain (allodynia)","volume":"86","author":"Muratani","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2020.173194_bib25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pain.2009.05.024","article-title":"Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: a putative animal model of fibromyalgia","volume":"146","author":"Nagakura","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2020.173194_bib26","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pain.2007.08.028","article-title":"Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial","volume":"133","author":"Nurmikko","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2020.173194_bib27","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/sj.bjp.0707423","article-title":"Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors","volume":"152","author":"O'Sullivan","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173194_bib28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.neuropharm.2006.08.011","article-title":"Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats","volume":"52","author":"Petrosino","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2020.173194_bib29","first-page":"849623","article-title":"Micronized palmitoylethanolamide reduces the symptoms of neuropathic pain in diabetic patients","volume":"2014","author":"Schifilliti","year":"2014","journal-title":"Pain Res. Treat."},{"key":"10.1016\/j.ejphar.2020.173194_bib30","doi-asserted-by":"crossref","first-page":"18150","DOI":"10.1073\/pnas.1113444108","article-title":"The major central endocannabinoid directly acts at GABA(A) receptors","volume":"108","author":"Sigel","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2020.173194_bib31","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jpain.2007.09.002","article-title":"Nabilone for the treatment of pain in fibromyalgia","volume":"9","author":"Skrabek","year":"2008","journal-title":"J. Pain"},{"key":"10.1016\/j.ejphar.2020.173194_bib32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11916-006-0043-x","article-title":"Pregabalin for neuropathic pain based on recent clinical trials","volume":"10","author":"Stacey","year":"2006","journal-title":"Curr. Pain Headache Rep."},{"key":"10.1016\/j.ejphar.2020.173194_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060040","article-title":"Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism","volume":"8","author":"Starowicz","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2020.173194_bib34","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.pain.2012.06.024","article-title":"An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain","volume":"153","author":"Toth","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2020.173194_bib35","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejphar.2010.02.025","article-title":"Spinal mechanism of standard analgesics: evaluation using mouse models of allodynia","volume":"634","author":"Tsukamoto","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173194_bib36","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejphar.2017.10.007","article-title":"In vitro and in vivo pharmacological characterization of ASP8477: a novel highly selective fatty acid amide hydrolase inhibitor","volume":"815","author":"Watabiki","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173194_bib37","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1126\/science.1063545","article-title":"Endocannabinoid signaling in the brain","volume":"296","author":"Wilson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2020.173194_bib38","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1073\/pnas.96.10.5780","article-title":"Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice","volume":"96","author":"Zimmer","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920302867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920302867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:38:40Z","timestamp":1757975920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920302867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":38,"alternative-id":["S0014299920302867"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173194","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ASP8477, a fatty acid amide hydrolase inhibitor, exerts analgesic effects in rat models of neuropathic and dysfunctional pain","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173194","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173194"}}